MONOCLONAL-ANTIBODY TO PROTEOGLYCAN DERIVED FROM GRIFOLA-FRONDOSA (MAITAKE)

被引:0
作者
HIRATA, A
ADACHI, Y
ITOH, W
KOMODA, M
TABATA, K
SUGAWARA, I
机构
[1] TOKYO COLL PHARM, IMMUNOPHARMACOL MICROBIAL PROD LAB, HACHIOJI, TOKYO 19203, JAPAN
[2] SAITAMA MED SCH, SAITAMA MED CTR, DEPT PATHOL, KAWAGOE, SAITAMA 350, JAPAN
关键词
MONOCLONAL ANTIBODY; PROTEOGLYCAN; GRIFOLA FRONDOSA; SCHIZOPHYLLAN; ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA);
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A murine monoclonal antibody (MAb) was prepared by immunizing BALB/c mice with a proteoglycan fraction derived from Grifola frondosa (Maitake mushroom), followed by the hybridization of spleen cells with mouse myeloma cells. The MAb (subclass; Ig G(2b)), designated MPG2, reacted with schizophyllan (SPG), curdlan, scleroglucan, laminarin and lentinan, but not with dextran, pullulan, mannan and xylan. Immunohistochemistry (ABC-GO method) shelved that MAb MPG2 reacted with lysosomal proteoglycan and (1->6)-beta-branched laminaritriose taken up by rabbit peritoneal macrophages. These results suggest that this MAb may recognize mainly (1->3)-beta-D-glucan, and may be useful for determining the immunological properties of Grifola frondosa-derived proteoglycan.
引用
收藏
页码:539 / 542
页数:4
相关论文
共 15 条
[1]  
ADACHI K, 1987, CHEM PHARM BULL, V35, P262
[2]  
ADACHI K, 1988, CHEM PHARM BULL, V36, P1000
[3]  
HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205
[4]   PREPARATION AND CHARACTERIZATION OF MURINE ANTI-SCHIZOPHYLLAN MONOCLONAL-ANTIBODY, SPG1-HS [J].
HIRATA, A ;
ITOH, W ;
TABATA, K ;
KOJIMA, T ;
ITOYAMA, S ;
SUGAWARA, I .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1993, 57 (01) :125-126
[5]  
HIRATA A, 1993, BIOL PHARM BULL, V16, P1091
[6]   DIFFERENT MACROPHAGE POPULATIONS DISTINGUISHED BY MEANS OF FLUORESCENT POLYSACCHARIDES - RECOGNITION AND PROPERTIES OF MARGINAL-ZONE MACROPHAGES [J].
HUMPHREY, JH ;
GRENNAN, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) :221-228
[7]  
ITOH W, 1990, INT J IMMUNOPHARMACO, V12, P225
[8]  
NANBA H, 1987, CHEM PHARM BULL, V35, P1162
[9]  
OHNO N, 1986, CHEM PHARM BULL, V34, P2555
[10]  
OKAMURA K, 1986, CANCER, V58, P865, DOI 10.1002/1097-0142(19860815)58:4<865::AID-CNCR2820580411>3.0.CO